May 17, 2016 | Arthritis Program, Phase I, Press Release, Research
VICTORIA, BC – Eupraxia, an emerging pharmaceutical company focused on optimizing drug delivery, announced today the initiation of STEP UP – a phase I study of its lead investigational product (EP-104IAR), for the treatment of pain associated with osteoarthritis (OA)...
Apr 28, 2016 | News, Research
Eupraxia Pharmaceuticals was recently featured in the 2016 edition of Lifesciences BC published by Business in Vancouver. The article is entitled “Transforming proven drugs into safer, longer lasting and more effective treatments.”
